Circulating eNAMPT in Glaucoma: A Semi-Quantitative Plasma Analysis Before and After Nicotinamide Supplementation

Puntos clave

• Plasma eNAMPT levels enable sensitive detection, providing insights into glaucoma mechanisms and potential biomarkers.
• Results indicate a distinct pattern of circulating eNAMPT before and after nicotinamide supplementation in glaucoma patients.
• Assessment involved a semi-quantitative analysis of plasma samples from glaucoma patients and controls.
• This analysis highlights the potential for eNAMPT as a biomarker, yet further validation is required before clinical application.